GWAY Financial Facts

Net loss per common share - basic and diluted: -2.53
Interest income, net: -1.65M
See Full Income Statement

Current portion of loan payable: 8.85M
Other receivables: 127K
See Full Balance Sheet

Greenway Medical Technologies (GWAY) Earnings

  |   Expand Research on GWAY
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate -108.9% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +4.0% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/19/13 Q413 -$0.08-$0.02 -$0.06$35.5M$34.04M = Details
5/6/13 Q313 $0.01$0.07 -$0.06$33.8M$38.56M Details
2/12/13 Q213 $0.00$0.04 -$0.04$32.7M$35.62M Details
11/1/12 Q113 $0.03$0.02 +$0.01$32.8M$32.17M Details
8/29/12 Q412 $0.10$0.09 +$0.01$36.4M$34.36M Details
5/10/12 Q312 $0.08$0.04 +$0.04$32.9M$28.54M N/A Details
3/13/12 Q211 $1.70N/A N/A $29.1M$22.3M N/A Details